文献速递头颈部肿瘤放疗

局部晚期头颈鳞癌术前放疗后病理完全缓解的预后影响:3期临床研究再分析

Prognostic impact of pathological complete remission after preoperative irradiation in patients with locally advanced head and neck squamous cell carcinoma: re-analysis of a phase 3 clinical study.
PubMed 文献 · Radiat Oncol · 2019-12-12

该研究基于3期临床试验再分析222例局部晚期头颈鳞癌患者,其中72例对术前治疗无反应者接受手术。72例中25例(化疗组10例、放疗组15例)达病理完全缓解(pCR)。pCR患者5年局部控制、总生存、无进展生存、无远处转移生存均显著优于非pCR患者,多因素分析显示pCR为独立预后因素。

要点

  • 术前放疗或同步放化疗后达pCR的局部晚期头颈鳞癌患者预后显著更好。
  • pCR患者5年总生存83.3%,非pCR患者仅39.7%(p=0.0006)。
  • 多因素分析证实pCR是局部晚期头颈鳞癌的独立预后因素。

核心结论

  • 局部晚期头颈鳞癌患者接受术前放疗或同步放化疗后达到pCR是良好的预后因素,且为独立预后因素。

研究设计与样本

  • 3期临床试验再分析,共纳入222例新诊断III/IVM0期头颈鳞癌患者,随机分为术前同步放化疗组(n=104)和术前单纯放疗组(n=118)。
  • 平均随访59个月,72例对术前治疗无反应者接受原发灶切除伴或不伴颈淋巴结清扫,分析原发灶病理肿瘤反应与治疗预后的关系。
  • 采用Kaplan-Meier法和Cox回归多因素分析评估pCR对局部控制、总生存、无进展生存和无远处转移生存的影响。

主要发现

  • 72例无反应者中25例达到pCR,其中化疗组10例、放疗组15例。
  • pCR患者与非pCR患者的5年局部控制率分别为93.2%与67.7%(p=0.007)。
  • pCR患者与非pCR患者的5年总生存率分别为83.3%与39.7%(p=0.0006)。
  • pCR患者与非pCR患者的5年无进展生存率分别为76.1%与44.0%(p=0.009)。
  • pCR患者与非pCR患者的5年无远处转移生存率分别为90.4%与56.3%(p=0.005)。

关键数值与推荐

  • pCR患者5年局部控制93.2% vs 非pCR 67.7%(p=0.007)。
  • pCR患者5年总生存83.3% vs 非pCR 39.7%(p=0.0006)。
  • pCR患者5年无进展生存76.1% vs 非pCR 44.0%(p=0.009)。
  • pCR患者5年无远处转移生存90.4% vs 非pCR 56.3%(p=0.005)。
  • 多因素分析中pCR为独立预后因素,差异有统计学意义。

临床怎么用

  • 对于局部晚期头颈鳞癌接受术前放疗或同步放化疗的患者,术后病理达pCR提示预后良好,可作为预后评估依据。

局限性

  • 分析仅基于72例对术前治疗无反应并接受手术的患者,样本量有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: The purpose of this study was to determine the associations between pathological complete remission (pCR) and clinical outcomes in patients with locally advanced head and neck squamous cell carcinoma (HNSCC) who received preoperative radiotherapy or chemoradiotherapy in a phase 3 clinical study. METHODS: A total of 222 newly diagnostic stage III/IVM0 HNSCC patients were randomly assigned to a preoperative concurrent chemoradiotherapy group (n = 104) or preoperative radiotherapy alone group (n = 118). Over a mean follow-up of 59 months, 72 patients were defined as non-responders to preoperative therapy and subsequently underwent resection of the primary lesion with or without neck dissection. The relationship between the pathological tumor response of the primary lesion and treatment prognosis was analyzed. Kaplan-Meier and Cox regression multivariate analyses were performed to evaluate the impact of pCR on local control (LC), overall survival (OS), progression-free survival (PFS), and distant metastasis-free survival (DMFS). RESULTS: Among the 72 non-responders, 25 patients, 10 in the chemotherapy group and 15 in the radiotherapy group, achieved pCR. The 5-year LC, OS, PFS, and DMFS of pCR patients and non-pCR patients were 93.2% vs. 67.7% (p = 0.007), 83.3% vs. 39.7% (p = 0.0006), 76.1% vs. 44.0% (p = 0.009), and 90.4% vs. 56.3% (p = 0.005), respectively. In multivariate analysis, pCR is also an independent prognostic factor in prognosis, with statistically significant differences. CONCLUSION: pCR after preoperative radiotherapy or concurrent chemoradiotherapy is a good prognostic factor in locally advanced HNSCC. TRIAL REGISTRATION: Number:ChiCTR-TRC-114004322 Date:05 Mar, 2014.

来源:Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Wang K, Yi J, Huang X, et al. Prognostic impact of pathological complete remission after preoperative irradiation in patients with locally advanced head and neck squamous cell carcinoma: re-analysis of a phase 3 clinical study. Radiat Oncol. 2019. PMID: 31831042. doi:10.1186/s13014-019-1428-4

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。